2022
Quantification of upper limb dysfunction in the activities of the daily living in persons with multiple sclerosis
Pisa M, Ruiz J, DeLuca G, de Andres Crespo M, DelMastro H, Olson K, Triche E, Lo A. Quantification of upper limb dysfunction in the activities of the daily living in persons with multiple sclerosis. Multiple Sclerosis And Related Disorders 2022, 63: 103917. PMID: 35671673, DOI: 10.1016/j.msard.2022.103917.Peer-Reviewed Original ResearchConceptsNine-Hole Peg TestFinger-nose testUL dysfunctionMultiple sclerosisDaily livingDisease severity subgroupsUpper limb functionUpper limb dysfunctionCharacteristic curve analysisJonckheere-Terpstra testUL functionDisease stageLimb functionGrip strengthPeg TestClinical trialsDisease progressionLimb dysfunctionGlobal disabilityMultivariate regression modelKruskal-Wallis testPredictive valueSeverity subgroupsLinear regression analysisDysfunction
2015
Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders
Lo A, Ruiz J, Koenig C, Anderson B, Olson K, Triche E. Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders. Journal Of The Neurological Sciences 2015, 356: 77-82. PMID: 26139339, DOI: 10.1016/j.jns.2015.06.008.Peer-Reviewed Original ResearchConceptsNon-dominant sideMultiple sclerosisMultiple Sclerosis Walking Scale-12Six-Spot Step TestD-EREffects of dalfampridineMinute walk testHole Peg TestRoutine clinical careWalk respondersWalk testGait impairmentAmbulatory personsPeg TestGross dexterityClinical carePotential treatmentScale-12Block TestSclerosisGaitStep testRespondersFurther investigationSignificant improvement